Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments


Oct 2010
Imaging and image analysis solutions provider Genetix of New Milton, UK, has received US patent No. 7,776,584, aspects of which have been incorporated into the company’s ClonePix FL, a system used for screening and selection of cell lines producing biopharmaceuticals. Significantly reducing the time and cost associated with recombinant protein generation, the system has been validated for the specific detection of secreted antibodies as well as monomeric, cell surface and intrinsic GFP fusion proteins.

antibodiesbiopharmaceuticalsBiophotonicsBusinesscell surfaceClonePix FLenergyGenetixImage Analysisimaginginstrinsic GFP fusion proteinsmonomericpatentRapidScanrecombinant proteins generationscreeningselection of cell linesUK

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.